KARA MCKENDRY: Open Payments
NPI 1093067290 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 29 payments from 7 companies in 2025. Trend: 2023 $271 · 2024 $557 · 2025 $2,137
Consulting: $1,386Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $1,415 |
| Biogen, Inc. | 5 | $181 |
| ABBVIE INC. | 16 | $179 |
| TG Therapeutics, Inc. | 1 | $115 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
| EMD Serono, Inc. | 1 | $111 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: TYSABRI, BRIUMVI, ZEPOSIA, Mavenclad, UBRELVY, QULIPTA, KESIMPTA, VUMERITY.
Industry payments across PA — which companies pay providers there.
